Infinity Pharmaceuticals News

Infinity Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jul 3, 2023 16:57 ET

Infinity Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jun 20, 2023 08:02 ET

Infinity Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Mar 28, 2023 16:24 ET

Infinity Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Feb 23, 2023 17:27 ET

Infinity Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Feb 23, 2023 17:26 ET

Infinity Pharmaceuticals | 424B5: Prospectus

Jul 27, 2021 09:23 ET

Infinity Pharmaceuticals | EFFECT: Others

May 24, 2021 00:15 ET

Infinity Pharmaceuticals | 424B5: Prospectus

Feb 12, 2021 16:40 ET

Infinity Pharmaceuticals | 424B5: Prospectus

Feb 11, 2021 16:06 ET

Infinity Pharmaceuticals | 424B5: Prospectus

Jul 30, 2019 08:32 ET

Infinity Pharmaceuticals | 424B5: Prospectus

Jun 28, 2019 16:23 ET

Infinity Pharmaceuticals | EFFECT: Others

Apr 30, 2019 00:15 ET

Infinity Pharmaceuticals | EFFECT: Others

May 11, 2018 00:15 ET